Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2014
06/03/2014CA2568804C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
05/2014
05/30/2014WO2014081878A2 Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival
05/30/2014WO2014081820A1 Small molecule cftr correctors
05/30/2014WO2014081756A1 S1p and/or atx modulating agents
05/30/2014WO2014081732A1 Azaindole derivatives as jak3 inhibitors
05/30/2014WO2014081147A1 Organic compound and organic electroluminescent device comprising same
05/30/2014WO2014081134A1 Novel compound and organic electroluminescent element comprising same
05/30/2014WO2014081133A1 Organic compound and organic electroluminescent element comprising same
05/30/2014WO2014081131A1 Organic compound, and organic electro-luminescence device comprising same
05/30/2014WO2014079995A2 Novel inhibitor compounds of phosphodiesterase type 10a
05/30/2014WO2014079953A1 SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C-FUNCTIONALIZED DERIVATIVES THEREOF
05/30/2014WO2014031487A8 Bivalent inhibitors of iap proteins and therapeutic methods using the same
05/29/2014US20140148494 Spiro-oxindole mdm2 antagonists
05/29/2014US20140148467 Carboxamide Compounds and Methods for Using the Same
05/29/2014US20140148453 Sulfonamide compounds useful as cyp17 inhibitors
05/29/2014US20140148436 Akt protein kinase inhibitors
05/29/2014US20140148433 Bicyclic aza heterocycles, and use thereof
05/29/2014US20140148421 Organic compounds
05/29/2014US20140147477 Prodrugs of (1s,9s)-9-[[(1s)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems
05/29/2014US20140147386 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
05/28/2014EP2735567A1 Heterocyclic substituted pyrimidine compound
05/28/2014EP2734524A1 PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS, THEIR PREPARATION AND USE AS SIGMA LIGANDS
05/28/2014EP2734523A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors
05/28/2014EP2734522A1 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors
05/28/2014EP2734520A1 Heterocyclic compounds and uses thereof
05/28/2014EP2734510A2 Activators of class i histone deacetlyases (hdacs) and uses thereof
05/28/2014CN103827119A 新颖的有机电致发光化合物和使用该化合物的有机电致发光器件 Novel organic electroluminescent compounds and the use of the compounds are organic electroluminescent devices
05/28/2014CN103827118A 双环嘧啶酮化合物 Bicyclic pyrimidinone compounds
05/28/2014CN103827117A 作为人嗜中性粒细胞弹性蛋白酶抑制剂的四氢三唑并嘧啶衍生物 As human neutrophil elastase inhibitors tetrahydro triazolo pyrimidine derivatives
05/28/2014CN103827116A 用作LP-PLA<sub>2</sub>抑制剂的2,3-二氢咪唑并[1,2-c]嘧啶-5(1H)-酮化合物 Used as LP-PLA <sub> 2 </ sub> inhibitor 2,3-dihydro-imidazo [1,2-c] pyrimidin -5 (1H) - one compounds
05/28/2014CN103819480A 四芳基双金属卟啉的连续生产工艺 Continuous production process tetraaryl bimetallic porphyrin
05/28/2014CN103819479A 一种含嘧啶基团刚性共轭大环化合物及其制备方法和应用 Pyrimidine group containing rigid conjugated macrocyclic compounds and their preparation method and application
05/28/2014CN103819478A 阿拉格列汀中间体2-甲基-吡唑并[1,5-a]嘧啶-6-羧酸的制备方法阿拉格列汀 intermediate 2-methyl - pyrazolo [1,5-a] pyrimidine-6-carboxylic acid of
05/28/2014CN103819477A 一种6-(4-氯苯氧基)-四唑并[5,1-a]酞嗪的多晶型制备方法及其应用 One kind of 6- (4-chlorophenoxy) - tetrazolo [5,1-a] phthalazine polymorph preparation method and its application
05/28/2014CN103819476A 吡咯酮并吡唑类化合物及其作为药物的用途 Pyrrolidone and pyrazole compounds and their use as medicaments
05/28/2014CN103819475A 一种西他列汀及其盐的合成方法 A synthesis of sitagliptin and its salts
05/28/2014CN103819474A 一种托法替尼的制备方法 One kind Tropsch process for preparing imatinib
05/28/2014CN103819473A 一种甘脲树脂及其制备方法 One kind of glycoluril resin and preparation method
05/28/2014CN103819455A 新有机电致发光化合物和使用该化合物的有机电致发光设备 The new organic electroluminescent compounds and the use of the compound organic electroluminescent devices
05/28/2014CN103819381A 氮丙啶、哌嗪和三乙烯二胺的联合生产方法及装置 Aziridine, piperazine and joint production method and apparatus Triethylenediamine
05/28/2014CN103816156A 火木层孔菌中环二肽c2在抗禽流感h5n1病毒上的应用 Fire Phellinus Central dipeptide c2 applications in anti-bird flu h5n1 virus
05/28/2014CN103044951B 一类双对位给受体型卟啉分子的不对称合成方法及其用途 A class of double counterpoint to the acceptor-type molecules in the asymmetric synthesis of porphyrin and its use
05/28/2014CN102757435B 一种反式-3-吲哚基-4-吲哚并二氮杂卓环庚烷基-2,5-吡咯烷-2,5-二酮化合物及其制备方法 An anti-3-indol-4-indolo diazepino cycloheptyl group 2,5-2,5-dione compounds and methods
05/28/2014CN102574840B R-7-(3-氨甲基-4-甲氧基亚氨基-3-甲基-吡咯烷-1-基)-1-环丙基-6-氟-4-氧代-1,4-二氢-[1,8]萘啶-3-羧酸l-天冬氨酸盐及其制备方法以及包含该盐的抗菌用药学组合物 R-7- (3- aminomethyl-4-methoxyimino-3-methyl - pyrrolidin-1-yl) -1-cyclopropyl-6-fluoro-4-oxo-1,4 - dihydro - [1,8] naphthyridine-3-carboxylic acid l- aspartic acid salts and salts comprising the preparation and pharmaceutical composition for antibacterial
05/28/2014CN102295555B 环丙基羧酸酯及其衍生物的制备方法 Preparation of cyclopropyl carboxylic acid esters and derivatives thereof
05/28/2014CN102264742B 3-(3-嘧啶-2-基苄基)-1,2,4-三唑并[4,3-b]哒嗪衍生物 3- (3-pyrimidin-2-yl) -1,2,4-triazolo [4,3-b] pyridazine derivatives
05/28/2014CN102227429B 作为趋化因子受体调节剂的3-氨基环戊烷羧酰胺 As chemokine receptor modulators of 3-amino-cyclopentane-carboxamide
05/28/2014CN101889011B 6,7-二氢-5H-咪唑并[1,2-a]咪唑-3-羧酸酰胺的衍生物 6,7-dihydro -5H- imidazo [1,2-a] imidazole-3-carboxylic acid amide derivative
05/28/2014CN101821269B 2-((r)-2-甲基吡咯烷-2-基)-1h-苯并咪唑-4-甲酰胺晶形2 2 - ((r) -2- methyl-pyrrolidin-2-yl) -1h- benzimidazole-4-carboxamide crystalline form 2
05/27/2014US8735574 Methods for synthesizing metal mesoporphyrins
05/27/2014US8735439 Chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same
05/27/2014US8735421 Imidazoquinolinyl sulfonamides
05/27/2014US8735408 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/27/2014US8735405 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
05/27/2014US8735404 Inhibitors of Bruton's tyrosine kinase
05/27/2014US8735403 Inhibitors of Bruton's tyrosine kinase
05/27/2014US8735402 Cycloalkyloxycarboxylic acid derivatives
05/27/2014CA2752738C Small molecule inhibitors of mdm2 and uses thereof
05/27/2014CA2707349C Organic compounds useful as inhibitors of phosphodiesterase 1
05/27/2014CA2684086C Process for hcv protease inhibitor intermediate
05/27/2014CA2633243C Azepinoindole derivatives as pharmaceutical agents
05/27/2014CA2624829C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
05/27/2014CA2620534C Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
05/22/2014WO2014078813A1 Compounds and compositions for the treatment of parasitic diseases
05/22/2014WO2014078690A1 Di-macrocycles
05/22/2014WO2014078637A1 Novel heterocyclic derivatives as modulators of kinase activity
05/22/2014WO2014078634A1 Novel imidazol-piperidinyl derivatives as modulators of kinase activity
05/22/2014WO2014078611A1 Dihydropyrazole gpr40 modulators
05/22/2014WO2014078609A1 Pyrrolidine gpr40 modulators
05/22/2014WO2014078578A1 Pyrrolopyrimidine compounds as kinase inhibitors
05/22/2014WO2014078408A1 Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014078372A1 Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
05/22/2014WO2014077401A1 Nitrogen-containing heterocyclic compound
05/22/2014WO2014076917A1 Organic el multicolor light emitting device
05/22/2014WO2014076237A1 Triazolopyrazine
05/22/2014WO2014076170A1 Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as|sigma receptors ligands
05/22/2014WO2014076162A1 Aminoimidazopyridazines
05/22/2014WO2014076146A1 Triazolopyridazine
05/22/2014WO2014075168A1 Pyrazolopyrimidine compounds
05/22/2014WO2014075146A1 Macrocyclic compounds and uses thereof
05/22/2014US20140142307 Azolium and purinium salt anticancer and antimicrobial agents
05/22/2014US20140142306 CDK Inhibitors
05/22/2014US20140142299 CDK Inhibitors
05/22/2014US20140142298 SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C-FUNCTIONALIZED DERIVATIVES THEREOF
05/22/2014US20140142126 Pyrrolopyrimidine compounds as kinase inhibitors
05/22/2014US20140142125 Synthetic Rigidin Analogues as Anticancer Agents, Salts, Solvates and Prodrugs Thereof, and Method of Producing Same
05/22/2014US20140142123 Inhibitors of bruton's tyrosine kinase
05/22/2014US20140142122 Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival
05/22/2014US20140142121 Mitochondria-targeted anti-tumor agents
05/22/2014US20140142110 Kinase inhibitor
05/22/2014US20140142098 Triazolopyrazine
05/22/2014US20140142093 Tricyclic oxazolidinone antibiotic compounds
05/22/2014US20140142090 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases
05/21/2014EP2733205A1 Corticospinal upper motor neurons, methods and compositions for differentiating neural stem cells by modulating CB1 cannabinoid receptor signaling and uses thereof
05/21/2014EP2733144A1 Novel compound having parp inhibitory activity
05/21/2014EP2733143A1 Substituted pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma receptors ligands
05/21/2014EP2731949A2 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
05/21/2014EP2731948A1 Novel substituted indole derivatives as gamma secretase modulators
05/21/2014EP2731940A1 4 - piperidinyl compounds for use as tankyrase inhibitors
05/21/2014CN103814030A 吡咯并嘧啶及嘌呤衍生物 Pyrrolopyrimidine and purine derivatives
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 573